×
About 50 results

ALLMedicine™ Aids-related Lymphomas Center

Research & Reviews  20 results

Survival of HIV-infected patients with high-grade non-Hodgkin's lymphomas: A retrospect...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7498086
PloS One; Manyau MCP, Mudzviti T et. al.

Sep 18th, 2020 - Rituximab in combination with chemotherapy is now widely accepted as standard of care for AIDS-related lymphomas (ARLs) of B-cell origin. However, the clinical impact of rituximab in resource limited settings remains unknown. Different settings an...

AIDS-related lymphomas: Treatment of systemic lymphoma
https://www.uptodate.com//contents/aids-related-lymphomas-treatment-of-systemic-lymphoma
Lawrence D Kaplan

INTRODUCTION Human immunodeficiency virus (HIV) infection results in impaired cellular immunity, a condition known to predispose persons to develop neoplasms. As the lifespan of HIV-infected patients has increased, malignancies have become a known...

Treatment and prognosis of primary central nervous system lymphoma
https://www.uptodate.com//contents/treatment-and-prognosis-of-primary-central-nervous-system-lymphoma
Tracy Batchelor

INTRODUCTION Primary central nervous system lymphoma (PCNSL) is an uncommon variant of extranodal non-Hodgkin lymphoma (NHL) that involves the brain, leptomeninges, eyes, or spinal cord without evidence of systemic disease. The treatment, complica...

Pulmonary manifestations of AIDS-related lymphomas
https://www.uptodate.com//contents/pulmonary-manifestations-of-aids-related-lymphomas
Michael Ieong

INTRODUCTION Human immunodeficiency virus (HIV) infection is associated with an increased incidence of lymphoma. The majority of AIDS-related lymphomas are aggressive, non-Hodgkin lymphoma (NHL) of B cell origin; nearly 60 percent are diffuse larg...

AIDS-related lymphomas: Epidemiology, risk factors, and pathobiology
https://www.uptodate.com//contents/aids-related-lymphomas-epidemiology-risk-factors-and-pathobiology
Lawrence D Kaplan

INTRODUCTION Human immunodeficiency virus (HIV) infection results in impaired cellular immunity, which predisposes to development of cancers [ 1-4 ]. As the lifespan of HIV-infected patients has lengthened, malignancies increasingly contribute to ...

see more →